Ambulatory Glucose Profile(AGP)
Definition
A standardized one-page glucose report recommended by the International Diabetes Center that summarizes 14 days of CGM data into a visual profile showing median glucose, interquartile range (25th to 75th percentile), and 10th to 90th percentile bands across a 24-hour period. The AGP report also includes key metrics such as time in range, time above range, time below range, GMI, CV, and mean glucose. Clinicians use AGP reports to identify glucose patterns — such as consistent post-lunch spikes or overnight lows — and adjust treatment accordingly.
Why “Ambulatory Glucose Profile” Matters for Glucose Monitoring
Understanding ambulatory glucose profile is essential for anyone using or evaluating a continuous glucose monitor. This concept directly affects how CGM devices are designed, how glucose data is interpreted, and how clinical decisions about blood sugar management are made. CGM metrics transform thousands of raw glucose readings into actionable numbers that clinicians use to assess glucose control, adjust medications, and set treatment goals.
This term is particularly relevant to 3 CGM products in our database. Understanding AGP helps you compare devices more effectively and choose the right continuous glucose monitor for your specific needs.
Related Terms
The percentage of time a person's glucose level remains within a defined target range, typically 70 to 180 mg/dL for most people with diabetes.
An estimated A1C value calculated from CGM mean glucose data, allowing users to track their A1C-equivalent in real time without requiring a laboratory blood draw.
A standardized measure of glucose variability calculated as the standard deviation of glucose values divided by the mean glucose, multiplied by 100, expressed as a percentage.
The magnitude and frequency of blood glucose fluctuations over a defined period.
A natural rise in blood glucose that occurs between approximately 3:00 AM and 8:00 AM, triggered by the body's circadian release of cortisol, growth hormone, and other counter-regulatory hormones that stimulate hepatic glucose production.